Author:
Zhangdi Hanjing,Geng Xinyu,Li Ning,Xu Ruiling,Hu Ying,Liu Jingyang,Zhang Xu,Qi Jihan,Tian Yingying,Qiu Jiawei,Huang Shiling,Cang Xueyu,Jin Shizhu
Funder
Harbin Medical University
Reference34 articles.
1. Evidence‐based clinical practice guidelines for liver cirrhosis 2020;Yoshiji;Hepatol. Res.,2021
2. Burden of liver diseases in the world;Asrani;J. Hepatol.,2019
3. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Sepanlou;The Lancet Gastroenterology & Hepatology,2020
4. Predictive biomarkers for checkpoint Inhibitor-based Immunotherapy in hepatocellular carcinoma: where do we stand?;Rizzo;Front. Oncol.,2021
5. Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis;Li;Canadian Journal of Gastroenterology and Hepatology. 2018,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献